These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2650258)

  • 41. Absence of auto-antiidiotypic activity between the IgM and IgG fractions of human mixed cryoglobulins.
    Stone GC; Nardella FA; Oppliger IR; Mannik M
    J Immunol; 1988 May; 140(9):3114-9. PubMed ID: 3129510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-B27 and ankylosing spondylitis: an anti-idiotypic model.
    McLean IL; Adams DD; Highton J
    J Clin Lab Immunol; 1985 Nov; 18(3):123-7. PubMed ID: 3878886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An anti-idiotypic antibody against Graves' IgG.
    Hawe BS; Farid NR
    Acta Endocrinol Suppl (Copenh); 1987; 281():152-4. PubMed ID: 3497507
    [No Abstract]   [Full Text] [Related]  

  • 44. Demonstration of anti-idiotypic antibodies directed against IgM rheumatoid factor in the serum of rheumatoid arthritis patients.
    Hancock WK; Barnett EV
    Clin Exp Immunol; 1989 Jan; 75(1):25-9. PubMed ID: 2702773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-idiotypic antibodies to HLA-DR4 and DR2.
    Reed E; Bonagura V; Kung P; King DW; Suciu-Foca N
    J Immunol; 1983 Dec; 131(6):2890-4. PubMed ID: 6417234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM.
    Perek Y; Hurwitz E; Burowski D; Haimovich J
    J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of allergen-specific IgE and IgG responses by anti-idiotypic antibodies.
    Nagpal S; Shanthi KN; Kori R; Schroder H; Metcalfe DD; Subba Rao PV
    J Immunol; 1989 May; 142(10):3411-5. PubMed ID: 2785554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of memory cells in vitro with an antiidiotype serum against the recognition structure specific for cells primed for histocompatibility determinants.
    Strong DM; Ahmed A; Leapman SB; Gawith K; Goldman MH; Smith AH; Sell KW
    Transplant Proc; 1979 Mar; 11(1):928-31. PubMed ID: 156440
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-idiotypic antibodies to HLA and their influence on patient sensitization.
    Reed E; Hardy M; Brensilver J; Lattes C; McCabe R; D'gati V; Reemtsma K; Suciu-Foca N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):762-3. PubMed ID: 3274865
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of anti-Fab antibodies on renal allografts.
    Feduska NJ; Chia D; Terasaki PI; Sugich L
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1277-8. PubMed ID: 1989211
    [No Abstract]   [Full Text] [Related]  

  • 51. [Importance of anti-idiotype antibodies in candidates for a renal graft].
    Seignalet J; Ramounau-Pigot A; Mourad G; Pouliquen M
    Nephrologie; 1991; 12(5):251-5. PubMed ID: 1766534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplantation of highly sensitized patients based on crossmatches using DTT-treated sera.
    Alarif L; Snyder T; Light JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):742-4. PubMed ID: 2650251
    [No Abstract]   [Full Text] [Related]  

  • 53. Specific crossmatch-inhibition by antiidiotypic antibodies against human alloreactive antibodies.
    Greger B; Hebart H; Büsing M; Hopt UT; Lauchart W
    Transplant Proc; 1990 Aug; 22(4):1890-1. PubMed ID: 2117816
    [No Abstract]   [Full Text] [Related]  

  • 54. Further evidence of a third HL-A locus.
    Solheim BG; Bratlie A; Sandberg L; Staub-Nielsen L; Thorsby E
    Tissue Antigens; 1973; 3(6):439-53. PubMed ID: 4130127
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants.
    Cross DE; Whittier FC; Weaver P; Foxworth J
    Transplant Proc; 1977 Dec; 9(4):1803-6. PubMed ID: 341439
    [No Abstract]   [Full Text] [Related]  

  • 56. Preformed antibodies in predicting clinical renal graft outcome.
    Smit JA; Stark JH; Margolius L; Thomson P; Botha JR; Meyers AM; Myburgh JA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):413-4. PubMed ID: 1990572
    [No Abstract]   [Full Text] [Related]  

  • 57. Autologous anti-antiidiotypic clones in human beings.
    Zouali M; Eyquem A
    N Engl J Med; 1984 Aug; 311(9):603. PubMed ID: 6431286
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of Fab anti-IgG in phenotyping IgG-sensitised red cells.
    Henry SM; Baird SJ; Woodfield DG
    Vox Sang; 1987; 53(3):147-50. PubMed ID: 3500540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of canine renal allografts. II. Studies with Fab fragments.
    Martin DC; Blackwelder R; Rasband R; Morton ME
    Trans Am Assoc Genitourin Surg; 1976; 68():99-101. PubMed ID: 801216
    [No Abstract]   [Full Text] [Related]  

  • 60. Induction of alloreactive suppressor cells by rabbit-derived anti-idiotypic antibodies.
    Greger B; Hebart H; Büsing M; Hopt UT; Lauchart W
    Transplant Proc; 1991 Aug; 23(4):2250. PubMed ID: 1831306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.